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aligning cells, microfabrication techniques have been widely 
investigated to build surfaces with varying topologies. [ 26–28 ] For 
example, cardiomyocytes have been seeded on both grooved 
and fl at surfaces, and cells cultured on the grooved pattern 
were more effective in aligning themselves, whereas the fl at 
surface leads to randomly adhered cells with a low level of 
intracellular organization. [ 27,28 ] In addition to these studies, 
several reports have focused on engineering 3D micropil-
lars, [ 29 ] micropumps, [ 30 ] and microcantilevers [ 31–33 ] as models 
for cardiac cell studies. Moreover, Feinberg et al. produced 
polydimethylsiloxane (PDMS) thin fi lms containing cardio-
myocytes in an arranged pattern and induced cell movement 
through directionally applied electric fi elds. [ 34 ] Using a similar 
concept, the same group further developed a microstructure 
that resembles the movement of jellyfi sh. [ 35 ] Other attempts 
have been made to improve cardiac cell culture platforms by 
incorporating hydrogels into cell culture substrates; Cvetcovic 
et al. utilizes 3D printing to build hydrogel/C2C12 skeletal 
muscle “biobots.” [ 36,37 ] While such examples to date present 
meaningful improvements on the performance and usability of 
biointegrated structures, there is still a need for new types of 
microactuating devices that can further basic studies on in vitro 
3D environments. 
 Here, we design and build compact and miniaturized biohy-
brid microcylinders that actuate in response to the spontaneous 
contraction of neonatal rat cardiomyocytes. We chose cardiac 
cells because they do not require application of an electric fi eld 
for stimulation. Anisotropic microcylinders were created via 
electrohydrodynamic (EHD) cojetting, a technique which pro-
vides easy functional materials processing. [ 38 ] We have previ-
ously reported bicompartmental poly( D , L -lactide- co -glycolide) 
(PLGA) microfi bers through EHD cojetting that are capable of 
guiding cell adhesion on individual fi bers. [ 15 ] Through surface 
modifi cation by covalent linkage of a cell adhesive peptide, we 
were able to demonstrate phase-selective cell attachment on a 
single microfi ber. [ 15 ] To construct a new class of synthetic bio-
actuators, we aim to guide cardiomyocytes onto single micro-
cylinders and to demosntrate cell-induced bending of the 
microcylinder. 
 A schematic diagram illustrating the preparation of the 
microcylinders is shown in  Figure  1 . First, bicompartmental 
microfi bers with a 20 µm diameter were produced via EHD 
cojetting. While PLGA was chosen as a base material for both 
compartments, cyclooctyne-functionalized poly(lactic acid) 
(COT-PLA) was selectively introduced in one of the compart-
ments. Cyclooctyne moieties are among the reactive groups 
commonly used in “click” chemistry under copper-free reac-
tion conditions. [ 39 ] To design microcylinders that can be actu-
ated by controlled cell action, it was important to control the 
alignment of the cells along the long axis of the microcylin-
ders. To this end, the incorporation of cyclooctyne groups in 
the microfi bers was necessary for rendering specifi c regions of 
the microcylinders protein repellent. In addition to COT-PLA, 
 Among many microactuator designs that have been developed 
and studied in recent years, bioactuators or biohybrid actuators 
are especially interesting due to the exploitation of living cells, 
their self-actuating behavior, and the potential promise for in 
vivo applications. [ 1–3 ] For example, integrating the spontaneous 
contraction of cardiomyocytes into complex polymer structures 
could generate spontaneous motion, only requiring a natural 
energy source such as glucose along with standard cell media. [ 4 ] 
To improve the performance of the actuating behavior of cells, 
recent work has involved the incorporation of carbon-based 
materials such as carbon nanotubes and graphene. [ 5,6 ] Because 
of their unique electrical conductivity and high mechanical 
properties, many reports have exploited the use of these mate-
rials to modulate electroactive tissue constructs or as a rein-
forcing agent for soft hydrogels. [ 7,8 ] Despite the importance of 
this work, biocompatibility and toxicity of carbon-based mate-
rials still remain unknown. Additionally, the fabrication of arti-
fi cial bioactuators becomes diffi cult at smaller scales and when 
3D structures are involved. With recent advances in the fi eld 
of polymer engineering, there has been improved control of 
the 3D cell culture environment. [ 9–12 ] Various nano- and micro-
fabrication techniques provide scaffolds with diverse scope 
of size, shape, or topology. [ 11,13–15 ] 3D structures are studied 
instead of merely 2D fi lms and the effect of pore architec-
tures on regulating cells is also under intense scrutiny. [ 16–18 ] 
Moreover, current research on the construction of microstruc-
tures with tunable functionalities has enabled direct control of 
cell behaviors such as cell adhesion, migration and prolifera-
tion. [ 19,20 ] In fact, a broad range of investigations have reported 
on engineering artifi cial cell culture matrices with specifi c 
functions such as being bioactive, [ 15,21 ] nonfouling, [ 22–24 ] or pos-
sessing stimuli-responsive [ 20,25 ] properties. 
 When creating bioactuators powered by cell movement, 
cell alignment on the device becomes a critical design com-
ponent for maximizing the output force. [ 7 ] As a strategy for 
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the microcylinders also contained magnetite nanocrystals 
with an average diameter of 15 nm. The addition of magnetite 
nanocrystals helped to separate the microcylinders from the 
cell culture, when replacing the cell media. Hence, the two 
solutions, PLGA/magnetite and COT-PLA/PLGA, were used 
to form well-defi ned bicompartmental microfi bers through 
EHD cojetting and the resulting microfi bers were further pro-
cessed by automated microsectioning to yield uniform micro-
cylinders following previously reported procedures. [ 38 ] In order 
to confi rm the selective localization of the cyclooctyne groups 
on the microcylinders, confocal Raman microspectroscopy was 
employed ( Figure  2 b). Raman analysis unambiguously con-
fi rmed that the presence of cyclooctyne groups was restricted 
to only one hemisphere. Once the spatially controlled loading 
of cyclooctyne groups was confi rmed, we next immobilized 
nonfouling poly(ethylene glycol) (PEG) via click chemistry with 
azide-functionalized PEG. 
 As an initial step, longer microfi bers were used in cell cul-
ture to ensure better attachment to the fl at support substrates 
that allowed for easy handling during protein and cell assays. 
In order to impose directional protein adsorption and cell 
growth, azide-functionalized PEG molecules were selectively 
introduced to the COT-PLA-containing compartment. As an 
indirect method to prove successful binding of antifouling PEG 
on the surface, fl uorescence-labeled bovine serum albumin 
(BSA, Alexa Fluor-647) was incubated with these PEG-modifi ed 
microfi bers for 3 h (Figure  2 a). As PEG molecules are protein 
repellent, BSA adsorbed only to the compartment lacking the 
cyclooctyne groups (Figure  2 a, center). This result was con-
sistent with a reference experiment without COT-PLA poly-
mers, which showed full coverage of BSA on the microfi bers 
(Figure  2 a, left). Likewise, shorter microcylinders modifi ed 
with PEG were similarly selective in repelling BSA adsorption 
(Figure  2 a, right). 
 To demonstrate the feasibility of these microfi bers and 
microcylinders for selective cell attachment, NIH 3T3 fi bro-
blasts were used. As seen in  Figure  3 , two different sets of 
microfi bers, PLGA/PLGA and PLGA/PEG (after surface immo-
bilization of PEG on COT-PLA), were utilized for the selective 
recruitment of cells. Due to the selective adsorption of cell-
adhesive protein fi bronectin (FN), the fi broblasts adhered and 
spread only on the compartment lacking PEG (Figure  3 c). In 
contrast, PLGA/PLGA microfi bers showed no selectivity on 
either the FN adsorption or the cell attachment (Figure  3 b). 
Next, we incubated biocompartmental microcylinders with NIH 
3T3 fi broblasts. Figure  3 d demonstrates successfully aligned 
and adhered NIH 3T3 fi broblasts after 8 h of incubation. 
 Before attempting to pattern cardiomyocytes on bicompart-
mental microcylinders, the mechanical properties of the micro-
cylinders had to be examined. PLGA is a biodegradable polymer 
which can be a good candidate for tissue engineering applica-
tions, [ 40 ] but its high stiffness and low strain were a potential 
problem for the intended use in bioactuation. [ 41 ] To overcome 
its limited mechanical properties, we prepared microcylinders 
composed of poly(lactide- co -caprolactone) (PLCL). In order to 
compare the mechanical properties of PLGA and PLCL micro-
fi bers, tensile tests of single fi bers were performed. Based on 
the stress–strain curves presented in Figure S1 (Supporting 
Information), it was demonstrated that the PLGA microfi bers 
had very low strain (0.1 ± 0.06) and higher Young’s modulus 
(1585 ± 551 MPa) than PLGA/PLCL (strain: 7.4 ± 1.3, Young’s 
modulus: 476 ± 31 MPa) microfi bers. PLCL shows a  T g of ≈16 °C 
and it is in a rubbery state at room temperature, thus pos-
sessing a much higher strain value than PLGA. [ 42–44 ] More-
over, when fracture strains for each microfi ber ( n = 10) were 
compared, PLGA/PLCL microfi bers tend to have more than 
70 times higher strain value than that of PLGA microfi bers. 
With this in mind, PLGA/PLCL microcylinders were incubated 
with NIH3T3 fi broblasts to characterize cell adhesion. The 
selective adhesion of NIH3T3 fi broblasts was unambiguously 
demonstrated after surface modifi cation of the microcylinders 
with PEG (Figure S2, Supporting Information). Furthermore, 
quantifi cation analysis shows that the two data sets of the 
microcylinders before and after the posttreatment with PEG 
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 Figure 1.  Fabrication of bicompartmental microcylinders for bioactuators. a) The fi rst step involves collecting fi bers as aligned bundles followed by 
cryosectioning at a desired length to prepare microcylinders. b) The second step is to utilize the obtained microcylinders for selective surface modifi ca-
tion with nonfouling PEG molecules. The immobilization of PEG on the half surface of microcylinders results in selective protein adsorption as well 
as cell attachment.











gave a  p -value <0.05, indicating that the PEGylated microcylin-
ders signifi cantly inhibit cell adhesion (Figure S2, Supporting 
Information). 
 Finally, to explore microcylinders as a biohybrid actuator, we 
studied neonatal cardiomyocytes, which spontaneously con-
tract even in the absence of an external current. The neonatal 
cardiomyocytes were seeded on the PLGA/PLCL microcylin-
ders.  Figure  4 shows the selective cultivation of cardiomyocytes 
on PLGA/PLCL microcylinders treated with PEG. As shown 
before, FN selectively adsorbed on the hemisphere lacking 
PEG, which then promoted cell adhesion and spreading. The 
concept of having PEG selectively on the one compartment 
was very important for the realization of the bending behavior 
of the microcylinders, as if the cells are randomly arranged, it 
would be impossible to observe synchronized contraction and 
there would not be any signifi cant net force. 
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 Figure 2.  Characterization of COT-functionalized bicompartmental microcylinders. a) Selective adsorption of BSA on bicompartmental microfi bers and 
microcylinders. CLSM images of the microfi bers before the surface modifi cation with PEG (left) shows BSA adsorbed to the entire fi ber surface. After 
the selective surface modifi cation with PEG (middle), BSA was adsorbed only on the unreacted surfaces. This result matched microcylinders (right), 
where the protein adsorption was prevented in the presence of the PEG chains. All scale bars are 20 µm. b) Confocal-Raman spectra obtained from 
the cross-sectional image scan of COT-functionalized bicompartmental microfi bers. Characteristic peak near 2200 cm −1 shows triple bond of carbon, 
which indicates the presence of the COT groups in the half compartment. The overlaid image demonstrates the localization of the COT groups (red) 
in one compartment only. Scale bar is 5 µm.












 Upon establishing the selective binding of cardiomyocytes, 
we further investigated the bending behavior of the obtained 
microcylinders for potential actuating applications. The 
autonomous beating of the cells was observed after 2 d in rat 
cardiomyocytes growth media. The actuating behavior of the 
microcylinders was then investigated on the third day of the 
experiment. Movies recorded for 25 s revealed that micro-
cylinders that were seeded with well-arranged cardiomyocytes 
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 Figure 3.  Selective recruitment of NIH 3T3 fi broblasts on bicompartmental microfi bers and microcylinders. a) Two different sets of experimental 
schemes, with and without surface modifi cation with PEG. b,c) CLSM images of bicompartmental microfi bers correspond to each step. (b) indicates 
the microfi bers before the surface modifi cation with PEG (blue compartment), where the fi broblasts were introduced on both compartments. In 
contrast, when the microfi bers were modifi ed with PEG, the cell attachment was observed on non-PEGylated compartment only. d) CLSM images of 
bicompartmental microcylinders after surface modifi cation with PEG (blue). The selective attachment of fi broblasts shows the presence of nonfouling 
PEG molecules in one half compartment. Scale bars in (b) and (c) are 50 µm and (d) is 20 µm.
 Figure 4.  Selective patterning of cardiomyocytes on bicompartmental PLGA/PLCL microcylinders. a) Experimental scheme showing surface modifi ca-
tion of one half compartments with PEG and cardiomyocytes seeding of another half compartments. b) The microcylinders showing selective recruit-
ment of cardiomyocytes on the non-PEGylated compartment only. All scale bars are 20 µm.











successfully underwent rhythmic bending, which was driven by 
synchronous beating of the heart cells (Movie S1, Supporting 
Information). Based on this fi nding, the actuation of the micro-
cylinders was estimated by analyzing the movies recorded by 
confocal laser scanning microscopy (CLSM). The bottom end 
point of the microcylinder was fi xed while the displacement of 
the top end point was measured directly from the video frame 
( Figure  5 ). 
 We found a signifi cant displacement from 9.75 to 18 µm, 
confi rming a clear bending action of the microcylinder in 
response to the beating neonatal cardiomyocytes. In fact, the 
microcylinder’s upper displacement was nearly double that 
of its initial starting point. We note that the stress of this 
experimental system can be modeled as a micropillar. [ 45 ] This 
approach assumes that the cells bending the microcylinder are 
selectively exhibiting a net force on the top, which is a reason-
able fi rst approximation, and the force needed to bend it from 
the sides would be even higher according to Tanaka et al. [ 46 ] L is 
the length of the microcylinder,  I is the geometric moment of 
inertia (here π d 4 /64 for a bending bar, where  d is the diameter 
of the microcylinder),  δ is the cylinder’s upper displacement, 
and  E is the Young’s modulus of the microcylinder. [ 47 ] We 
measured  E to be 476 ± 31 MPa,  L is 78.5 µm,  d is 20 µm,  I is 
7.854 × 10 −21 m 4 , and  δ is 8.25 µm. Equation  1 is then used to 
calculate the force of displacement: [ 45 ] 
 
δ= ⎛⎝⎜ ⎞⎠⎟3 3F EIL  
 (1)
 
 From this, we get a total force of 191 ± 12 µN. 
 In summary, a new approach to fabricate biohybrid micro-
cylinders is introduced. From our study, we can conclude that 
having anisotropic features with nonfouling PEG on a specifi c 
compartment signifi cantly infl uences cardiomyocytes to attach 
with an aligned direction along the long axis of the microcylin-
ders, which in turn, allows the microcylinders to deform their 
shapes in a controlled direction. Based on our experiments, 
we estimated a bending force of 191 ± 12 µN. This is a very 
large force in comparison to those measured for other bioac-
tuators. However, we attribute this exceptional performance 
that our microactuators have a far greater number of cardio-
myocytes per area than other rather macroscopic systems. For 
example, Akiyama’s dorsal vessel tissue robot exerted a force 
of 4.7 µN for bending of their microcylinders (though they 
were calculating the contracting force at the center of the 
pillar rather than the top). [ 47 ] Tanaka’s micropillars were bent 
with a force of 3.8 µN, which is unsurprising given that they 
only have one or a few cardiomyocytes attached. [ 46 ] Nishimura 
et al. averaged the amount of force generated by a single adult 
rat cardiomyocyte (with a population of 18 measured) with 
isometric conditions as 5.720 ± 0.41 µN. [ 48 ] Visual inspection 
of the cylinder reveals there are ≈26 cardiomyocytes attached, 
giving them an average individual force of ≈7.3 µN. This is 
not too far from the forces measured by Nishimura et al. for a 
single cardiomyocyte. 
 While further studies are needed to study the bending behav-
iors of the heart cells on these structures, the development of a 
single microcylinder that can be used for the integration of the 
motion of living cells may open new steps toward miniaturized 
biorobots or biomachines. 
 Experimental Section 
 Materials : PLGA (85:15,  M w = 50–75 000 g mol −1 ), PLCL (lactide 
86 mol%), Tween 20, poly[( m -phenylenevinylene)-alt-(2,5-dibutoxy- p -
phenylenevinylene)] (MEHPV), which was used as CLSM markers for 
blue emission, were purchased from Sigma–Aldrich, USA. COT-PLA was 
prepared as described elsewhere. Human plasma FN and albumin from 
bovine serum (BSA) (Alexa Fluor-647 Conjugate) were purchased from 
Life Technologies, USA. Iron oxide nanocrystals (15 nm in diameter) 
suspended in chloroform was purchased from Ocean Nanotech, USA, 
and 8-arm PEG-azide ( M w = 40 000 g mol −1 ) was purchased from 
Creative PEGWorks, USA. NIH 3T3 fi broblasts and primary rat cardiac 
myocytes were purchased from the American Type Culture Collection 
(ATCC) and Lonza, USA, respectively. The solvents chloroform,  N , N ′-
dimethyl formamide (DMF), and cyclohexane were purchased from 
Sigma–Aldrich, USA and were used without further purifi cation. 
 Microcylinder Characterization : The particles were visualized using a 
confocal laser scanning microscopy (Olympus, FluoView 500). A 405 nm 
laser and a 633 nm helium-neon red (HeNeR) laser were used to excite 
MEHPV and Alexa Fluor 647 (labeling dyes for BSA), respectively. The 
barrier fi lters were set to 430–460 nm for MEHPV and >660 nm for Alexa 
Fluor 647. Confocal Raman spectra were obtained with WITec alpha300R 
utilizing 532 nm laser. Microfi bers were dried under vacuum for 
overnight to remove any remaining solvents. The spectra were acquired 
using an integration time of 0.5 s per pixel with image scan area of 
100 pixels × 100 pixels. The mechanical properties of the microfi bers 
were determined by using NanoIndenter II (MTS/Nanoinstruments Inc., 
Oak Ridge, TN). Each end point of microfi ber was held to a piece of 
paper with epoxy glue for easy handling and was gripped to a sample 
holder for stretching. Stress–strain curves were obtained by testing a 
single fi ber with a diameter of 20 µm and a length ranges from 2 to 
Adv. Mater. 2015, 27, 4509–4515
www.advmat.de
www.MaterialsViews.com
 Figure 5.  Controlled bending behavior of PLGA/PLCL microcylinders 
driven by the spontaneous contraction of cardiomyocytes. Two CLSM 
images were captured from the video frame (top) and analyzed to calcu-
late the displacement of the top end point of the microcylinder (bottom). 
The displacement was measured from 9.75 to 18 µm indicating the defor-
mation of microcylinders was occurred upon the cell movement. All scale 
bars are 10 µm.
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5 mm depending on the sample size. Tensile tests were performed at a 
rate of 0.08 mm s −1 . The number of tested samples was 10 for each set. 
 Fabrication of Bicompartmental Microfi bers : The typical procedure 
for bicompartmental microfi bers is as follows. Two different polymer 
solutions were prepared in separate vials. A 30 w/v% of PLGA was 
dissolved in a solvent mixture of chloroform and DMF (95:5, v/v). 
Another solution contained 30 w/v% of PLGA and COT-PLA with a 
concentration of 9 w/v% (30% by weight of PLGA), which were dissolved 
in the same solvent ratio. More detailed information for the preparation 
of microfi bers created in this work is stated in Table S1 (Supporting 
Information). The experimental setup includes a syringe pump (Fisher 
Scientifi c, Inc., USA), a power supply (DC voltage source, Gamma 
High Voltage Research, USA), and a rotary collector. Each set of two 
polymer solutions was delivered at a constant fl ow rate of 0.05 mL h −1 
via vertically positioned syringes equipped with 26 G needles (Hamilton 
Company, USA). When a driving voltage of 11–12 kV was applied to 
the polymer solution, stable Taylor Cone was formed and fi bers were 
collected at a distance of 7 cm. 
 Fabrication of Bicompartmental Microcylinders : Bicompartmental 
microcylinders were prepared as previously reported method. [ 38 ] Briefl y, 
the obtained microfi bers (refer to Table S1, Supporting Information) 
were placed in a cryostat mold with a freezing medium and sectioned 
at a desired thickness using a cryostat microtome (Microm HM550, 
Thermo Fisher Scientifi c Inc., Germany). Once all the sections were 
collected, the microcylinders were washed extensively with 0.01 v/v% 
Tween 20/deionized (DI) water to remove any residual freezing medium. 
 Selective Surface Modifi cation via Copper-Free Click Chemistry : COT-
functionalized bicompartmental microfi bers were collected on a glass 
substrate and fi xed using double-sided tapes. The glass substrates 
for holding the microfi bers were PEGylated via atom transfer radical 
polymerization of oligo(ethyleneglyocol) methacrylate. It is important 
to note that in all cases PEGMA-coated substrate was placed with 
fi ber samples because they were proven to create nonfouling surfaces 
that can repel both protein adsorption and cell adhesion. [ 49,50 ] The 
microfi bers taped on the poly(ethylene glycol) methacrylate (PEGMA)-
coated substrate were then incubated with 45 mg of 8-arm PEG azide 
in 1 mL of DI water and the reaction was carried out in a 12-well plate 
by gentle agitation for 24 h at room temperature. After the reaction, the 
unreacted PEG azide was washed with 0.01 v/v% Tween 20/DI water. In 
the case of microcylinders, ≈50 000 cylinders were incubated with 45 mg 
of 8-arm PEG azide in an Eppendorf tube containing 1 mL of 0.01 v/v% 
Tween 20/DI water and were kept rotating for 24 h at room temperature. 
 BSA Incubation : After the click reaction, the microfi bers taped on 
the PEGMA substrate were placed in a 12-well plate and incubated 
with 100 µg of BSA in phosphate buffered saline (PBS) for 3 h at room 
temperature. The unreacted BSA molecules were removed by repeated 
washing with 0.01 v/v% Tween 20/PBS. In the case of microcylinders, 
50 000 cylinders were rotated with 200 µg of BSA in an Eppendorf tube 
containing 1 mL of 0.01 v/v% Tween 20/PBS for 3 h at room temperature. 
 Incubation of NIH3T3 Fibroblasts on Microfi bers : Prior to cell seeding, 
microfi bers with PEGMA-coated substrate were fi rst incubated with 
50 µg of FN in 1 mL of PBS and gently agitated in a 12-well plate for 
1 h at room temperature. After the FN incubation, the microfi bers 
were washed three times with PBS with an interval of 5 min in each 
wash. Next, NIH 3T3 fi broblasts were cultured with a concentration of 
5 × 106 cells mL −1 well −1 for 6 h in serum-free media. Passages 
3–6 were used for all experiments. The cells were then fi xed with 
4% paraformaldehyde in DPBS and were stained with 1 µL mL −1 of 
cytocalasin D (Life Technologies). 
 Incubation of NIH3T3 Fibroblasts on Microcylinders : FN (100 µg) 
was incubated with 50 000 microcylinders in an Eppendorf tube 
containing 0.01 v/v% PBS at a total volume of 1 mL and rotated for 
1 h at room temperature. Next, NIH 3T3 fi broblasts were cultured 
with a concentration of 5 × 106 cells mL −1 for 4 h by using a rotator in 
the incubator. After 4 h of rotation, the samples were transferred into 
a 12-well plate with PEGMA surfaces and continued to incubate for 
another 4 h. Finally, the cells were fi xed with 4% paraformaldehyde in 
Dulbecco’s phosphate buffered saline (DPBS) before imaging. 
 Incubation of Cardiomyocytes : The PEGMA-coated surfaces and 
microcylinders were sterilized under UV lamp for overnight at room 
temperature prior to use. The microcylinders (50 000 cylinders mL −1 ) 
were fi rst incubated with FN in DI water with a concentration of 
100 µg mL −1 in an Eppendorf tube. This was rotated for 1 h at room 
temperature. After the FN incubation, the microcylinders were washed 
three times with sterile DPBS with an interval of 5 min in each wash. 
Next, we added primary rat cardiac myocytes (800 000 cells mL −1 ) to 
the solution containing microcylinders and rotated with media (rat 
cardiac myocyte basal medium, Lonza) supplemented with 5-bromo-
2′-deoxyuridine (BrdU) in order to prevent fi broblast proliferation. After 
4 h of rotation, 80% of the media was replaced to freshly prepared media 
with 5-bromo-2′-deoxyuridine (BrdU). The solution was kept rotating for 
another 4 h and transferred into a 24-well plate along with the PEGMA-
coated surface. After 24 h, 1 µmol L −1 of aldosterone (Sigma–Aldrich) 
dissolved in ethanol was added to the media in order to enhance 
cardiomyocyte beating. The samples placed in the well plate were then 
kept in the incubator until the day 3 and were imaged through CLSM. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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